Gene: MFSD13A
Official Full Name: major facilitator superfamily domain containing 13Aprovided by HGNC
Gene Summary: Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16194 | MFSD13A Knockout cell line (HeLa) | Human | MFSD13A | 1:3~1:6 | Negative | Online Inquiry |
KO16195 | MFSD13A Knockout cell line (HCT 116) | Human | MFSD13A | 1:2~1:4 | Negative | Online Inquiry |
KO16196 | MFSD13A Knockout cell line (HEK293) | Human | MFSD13A | 1:3~1:6 | Negative | Online Inquiry |
KO16197 | MFSD13A Knockout cell line (A549) | Human | MFSD13A | 1:3~1:4 | Negative | Online Inquiry |
MFSD13A Gene Knockout Cell Lines represent a cutting-edge cellular model specifically engineered to lack the MFSD13A gene, which is implicated in various physiological processes, including lipid metabolism and neurological functions. These knockout cell lines are generated using advanced genome-editing technologies such as CRISPR-Cas9, which ensures precise alterations in the genomic DNA. The deletion of the MFSD13A gene allows researchers to investigate its biological role and underlying mechanisms without the confounding effects of gene expression, making it an invaluable tool in functional genomics.
The primary function of these cell lines is to facilitate the study of cellular pathways influenced by the MFSD13A gene. By observing the phenotypic and biochemical changes that occur in the absence of this gene, scientists can elucidate the molecular mechanisms that govern lipid homeostasis and neuronal development. This insight is crucial for understanding diseases such as obesity and neurodegeneration, where MFSD13A has shown relevance.
In research and clinical settings, MFSD13A Gene Knockout Cell Lines are of paramount importance as they aid in the identification of potential therapeutic targets. For instance, the ability to modulate lipid metabolic pathways opens avenues for developing medications aimed at managing metabolic disorders. Furthermore, their applicability extends to drug testing and biomarker discovery, essential in both academic and pharmaceutical research.
What sets our MFSD13A Gene Knockout Cell Lines apart from other models is our commitment to quality and characterization. Each cell line undergoes rigorous validation processes, ensuring stable gene knockout and consistent performance. Additionally, we provide comprehensive technical support and user-friendly protocols, streamlining the integration of these models into diverse research workflows.
Our MFSD13A Gene Knockout Cell Lines offer researchers and clinicians a dependable and innovative resource for their studies, ultimately advancing our understanding of key biological processes. With a solid background in developing state-of-the-art biological products, our company remains dedicated to empowering the scientific community with high-quality tools that drive discovery and innovation in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.